<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Aarup Honore | Activity</title>
	<link>https://www.catswannabecats.com/members/twinehubcap16/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/twinehubcap16/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Aarup Honore.</description>
	<lastBuildDate>Thu, 25 Jun 2026 06:52:40 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">292c3ecd1be0cc0d96f1fce16b9b9a52</guid>
				<title>Aarup Honore posted an update: As the most popular intrinsic neoplasm throughout the brain, [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/25271/</link>
				<pubDate>Sun, 08 Jun 2025 19:07:11 -0400</pubDate>

									<content:encoded><![CDATA[<p>As the most popular intrinsic neoplasm throughout the brain, glioblastoma multiforme (GBM) is resistant to existing therapies. Due to its invasive nature, GBM shows a poor prognosis despite aggressive surgery and chemoradiation. Therefore, identifying and understanding the critical molecules of GBM can develop new therapeutic strategies.&hellip;<span class="activity-read-more" id="activity-read-more-25271"><a href="https://www.catswannabecats.com/activity/p/25271/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9578d8833212e42425ab57ccea30c142</guid>
				<title>Aarup Honore posted an update: were also needed to be formulated based on the prognostic [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/22988/</link>
				<pubDate>Sat, 07 Jun 2025 16:14:41 -0400</pubDate>

									<content:encoded><![CDATA[<p>were also needed to be formulated based on the prognostic factors in order to improve the prognosis of patients.Objective This study was to investigate the perioperative safety of cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) for pseudomyxoma peritonei (PMP), and analyze the risk factors of serious adverse&hellip;<span class="activity-read-more" id="activity-read-more-22988"><a href="https://www.catswannabecats.com/activity/p/22988/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">38abc26f70f388bfeee302f8727a2882</guid>
				<title>Aarup Honore posted an update: The Army Marches on its Stomach". To provide nutritious, [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/8900/</link>
				<pubDate>Sat, 31 May 2025 21:50:57 -0400</pubDate>

									<content:encoded><![CDATA[<p>The Army Marches on its Stomach&#8221;. To provide nutritious, wholesome, safe and quality food to the large Indian Armed Forces, spread over various terrains, ranging from the icy Himalayas to the burning deserts of Rajasthan or the humid jungles of the North East and over various platforms like tanks, ships and aircraft is a challenge. The major issue&hellip;<span class="activity-read-more" id="activity-read-more-8900"><a href="https://www.catswannabecats.com/activity/p/8900/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f3afb6aa8ab37c787127d5cb21b2fdf8</guid>
				<title>Aarup Honore became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/8751/</link>
				<pubDate>Sat, 31 May 2025 21:37:46 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>